
Kymos
Frankfurt/Main, Germany kymos.com From their website, Nov 2026
- GLP
- GMP
Work here? Claim this listing
About
Kymos is a European contract research organization providing bioanalytical and CMC services for small molecules, biologics, TIDES, and cell and gene therapies. It serves pharma, biotech, generic, biosimilar, and veterinary clients from laboratories in Barcelona, Frankfurt, and Ancona, with additional sites in Denmark and South Korea. It supports work across early research through clinical development, quality control, and commercialization.
Services
Pre-clinical & Clinical Bioanalysis
Bioanalysis services for preclinical and clinical studies, including small molecules, biologics, nucleic acids, biomarkers, percutaneous absorption, enzyme activity, and pharmacokinetic evaluation.
Bioanalysis of Small Molecules & Generics
GLP-certified and GCP-compliant bioanalysis for small molecules across preclinical, clinical, and bioequivalence studies.
Bioanalysis for Animal Health
GLP-compliant bioanalytical services for veterinary drug development, bioequivalence studies, and residue depletion studies.
Bioequivalence Studies
End-to-end bioequivalence services from study design and protocol writing through clinical execution, reporting, and regulatory submission support.
Bioanalysis & Immunogenicity of Biologics & Biosimilars
Method development, validation, and sample measurement for biologics and biosimilars, including immunogenicity-related work.
Bioanalysis of Nucleic Acids
Quantification of nucleic acids as therapeutics, biomarkers, or similar analytes using standardized methods.
Biomarker Analysis
Biomarker analysis services for multiple therapeutic areas using multiplexing techniques and advanced equipment.
CMC Analysis & Quality Control
CMC testing and quality control for pharmaceutical products, including GMP-certified services for multiple molecule types.
12 more services
- Method Development, Validation and Transfer
- Raw Material Testing
- Quality Control of Small Molecules
- Quality Control of Oligonucleotides
- Quality Control of Biologics and Biosimilars
- Biosimilar Comparability Studies
- Batch Testing & Batch Release
- Viral Vectors Characterization
- Stability Studies
- Particle Characterization
- Foreign Particle Identification
- Cell-Based and Potency Assay
- Minimums and prices
- Method development and validation is free of charge
Capabilities
- Assays and studies
- Bioanalysis
- Small molecules
- Peptides
- PK/PD
- Oligonucleotides
- Stability studies
12 more
- Immunogenicity
- Analytical development
- LC-MS/MS
- HRMS
- ICP-MS
- ELISA
- ECLA
- RIA
- Phoenix WinNonlin®
- Meso QuickPlex SQ
- IVRT
- IVPT
- Scale and capacity
- 4 laboratories
- 14 laboratory departments
- 240 highly trained experts
- 5,000 m2 of facilities
- 100 m3 of SCADA-monitored sample storage chambers
- Therapeutic areas
- Veterinary
- Biopharmaceuticals
- Biosimilars
- Generic medicines
Instruments and platforms
- LC-MS/MS
- HRMS
- ICP-MS
- Phoenix WinNonlin®
- Meso QuickPlex SQ
Modalities and species
- Modalities
- Small molecule
- ADC
- Peptide
- Oligonucleotide
- Viral vector
- Cell therapy
3 more
- Vaccine
- Biosimilar
- LNP / formulation
- Species and models
- Rats
- Mice
- Rabbits
- Mini pigs
- Cats
- Dogs
6 more
- Non-human primates
- Swine
- Cattle
- Sheep
- Poultry
- Horses
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: quality control and selected bioanalysis services
FDA registrationSelf-reported
GLPSelf-reported
Scope: bioanalysis and selected quality control services
Company
- Type
- CRO
- Founded
- 2001
- Team
- 240 highly trained experts
Locations
- Office
- 60 DTU Science Park, Agern Allé 3 DK 2970, Hørsholm Copenhagen, Denmark Seoul, South Kore
- Sites
- Barcelona, Spain
- Frankfurt, Germany
- Ancona, Italy
- Serves
- Europe, over 60 countries worldwide